Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-65
SponsorCeragem Clinical Inc.
About this trial
This study is a single-center, open-label, exploratory clinical trial to evaluate the safety and efficacy of a statics electricity generator for improving blood circulation.
Eligibility criteria
Qualifiers
Adults aged between 19 and 65 years
Individuals with a BMI of 30.0 kg/m² or less
Individuals without abnormal findings on hematology tests (CBC)
Disqualifiers
Patients with uncontrolled hypertension despite medication (defined as systolic blood pressure ≥150 mmHg or diastolic blood pressure ≥100 mmHg measured at rest)
Patients with medical conditions requiring the use of assistive devices (e.g., pacemaker, artificial joint, stent, prosthesis, etc.)
Patients with seizure disorders or a history of loss of consciousness (e.g., epilepsy, acute febrile convulsions such as those associated with severe fever, etc.), or those at high risk of electric shock due to such conditions
Patients with ventricular arrhythmias (e.g., ventricular tachycardia, history of coronary artery bypass surgery, etc.) and patients with neurological disorders (e.g., diabetic neuropathy, etc.)
Trial design
Treatments tested in this trial
- CERAGEM CELLTRON CIRCULATION CHAIR (CGM MEPC-2401)
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov